Acute bronchiolitis in infancy as risk factor for wheezing and reduced pulmonary function by seven years in Akershus

Hans-Olav Fjaerli1, Teresa Farstad, Gisle Rød

  • 1Faculty Division, Akershus University Hospital, University of Oslo, 1474 Nordbyhagen, Norway. h.o.fjarli@medisin.uio.no

BMC Pediatrics
|August 20, 2005
PubMed

Insights

Infants hospitalized for acute viral bronchiolitis, regardless of the cause, experience more wheezing and reduced lung function by age seven. This suggests prolonged bronchial hyperreactivity can follow early-life respiratory infections.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Epidemiology

Background:

  • Acute viral bronchiolitis is a common cause of infant hospitalization, often linked to respiratory syncytial virus (RSV).
  • Early-life bronchiolitis can lead to long-term bronchial hyperreactivity and respiratory issues.
  • The study investigates long-term respiratory outcomes following any acute viral bronchiolitis in infancy.

Purpose of the Study:

  • To determine if infants hospitalized for acute viral bronchiolitis exhibit increased wheezing and reduced lung function up to age seven.
  • To compare outcomes between infants hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis.

Main Methods:

  • A cohort of 57 infants hospitalized for acute viral bronchiolitis was followed up at age seven.
  • A control group of 64 children without infant hospitalization for bronchiolitis was recruited.
  • Data collected retrospectively and via clinical interviews and examinations.

Main Results:

  • Hospitalized children showed decreased lung function, more wheezing episodes, and higher rates of asthma medication and follow-up at age seven.
  • Lower birth weight and parental asthma were more common in the hospitalized group.
  • No significant differences were found between RSV-positive and RSV-negative groups.

Conclusions:

  • Early-life hospitalization for bronchiolitis is associated with persistent wheezing and impaired lung function by age seven.
  • Prolonged bronchial hyperreactivity may occur after both RSV-positive and RSV-negative bronchiolitis.
  • Findings highlight the long-term respiratory impact of infant bronchiolitis.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: